HAMED KAMAL - Insider Non-Derivative Transactions at Spero Therapeutics, Inc. (SPRO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 2, 2024, HAMED KAMAL's relationship to Spero Therapeutics, Inc. (SPRO) is Officer (Chief Medical Officer), and currently has 788,117 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SPRO insiders.
Data Source: SEC.
HAMED KAMAL - Insider Non-Derivative Transactions of SPRO Common Stock
HAMED KAMAL - Insider Non-Derivative Transactions at SPRO
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Feb 3, 2024 | Sell -- (Common Stock) | 28075 | 1.37 | 788117 |
Feb 2, 2024 | Acquisition -- (Common Stock) | 239731 | 0 | 816192 |
Sep 14, 2023 | Sell -- (Common Stock) | 39496 | 1.27 | 576461 |
Jun 13, 2023 | Acquisition -- (Common Stock) | 140000 | 0 | 615957 |
Feb 2, 2023 | Acquisition -- (Common Stock) | 265957 | 0 | 475957 |